Work

nab-paclitaxel (nab-P) + carboplatin (C) induction therapy in patients (Pts) with squamous (SCC) NSCLC: Interim quality of life (QoL) outcomes from the phase 3 ABOUND.sqm study

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw383.79

Authors: M. Thomas, S. Ponce Aix, A. Ko, R. Jotte, T.J. Ong, R. Page, M. Socinski, N. Trunova, V. Villaflor, D.R. Spigel

Institutions: University Hospital Heidelberg, German Center for Lung Research, Spanish National Cancer Research Centre, Celgene (United States), Rocky Mountain Cancer Centers, Center for Cancer and Blood Disorders, University of Pittsburgh, University of Pittsburgh Medical Center, University of Chicago, University of Chicago Medical Center, Sarah Cannon

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Celgene, University of Chicago

OpenAlex ID: W2587946423

FWCI:

Cites:

Cited by:

Related to: 10